Galmed Pharmaceuticals (GLMD) Interest & Investment Income (2023)
Galmed Pharmaceuticals (GLMD) recorded quarterly Interest & Investment Income of $7000.0 in Q3 2023.
Galmed Pharmaceuticals (GLMD) Interest & Investment Income (2023) Analysis & Trends
Galmed Pharmaceuticals' Interest & Investment Income history runs 1 years deep, the most recent figure standing at $7000.0 for Q3 2023.
- In Q3 2023, Interest & Investment Income changed N/A year-over-year to $7000.0; the TTM figure through Sep 2023 stood at $7000.0 (changed N/A YoY), while the FY2020 annual figure was $1.2 million, down 38.97% from the prior year.
- Interest & Investment Income was $7000.0 for Q3 2023 at Galmed Pharmaceuticals.
- In the past five years, Interest & Investment Income ranged from a high of $7000.0 in Q3 2023 to a low of $7000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Galmed Pharmaceuticals | 2.48 Mn | -1.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 7,000.00 |